Literature DB >> 17662720

Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions.

Shunsuke Ohnishi1, Hideaki Sumiyoshi, Soichiro Kitamura, Noritoshi Nagaya.   

Abstract

Mesenchymal stem cells (MSC) transplantation has been shown to decrease fibrosis in the heart; however, whether MSC directly influence the function of cardiac fibroblasts (CFB) remains unknown. MSC-conditioned medium significantly attenuated proliferation of CFB compared with CFB-conditioned medium. MSC-conditioned medium upregulated antiproliferation-related genes such as elastin, myocardin and DNA-damage inducible transcript 3, whereas CFB-conditioned medium upregulated proliferation-related genes such as alpha-2-macroglobulin and v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog. MSC-conditioned medium significantly downregulated type I and III collagen expression, and significantly suppressed type III collagen promoter activity. MSC may exert paracrine anti-fibrotic effects at least in part through regulation of CFB proliferation and collagen synthesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17662720     DOI: 10.1016/j.febslet.2007.07.028

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  81 in total

1.  Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition.

Authors:  Yerem Yeghiazarians; Meenakshi Gaur; Yan Zhang; Richard E Sievers; Carissa Ritner; Megha Prasad; Andrew Boyle; Harold S Bernstein
Journal:  Cytotherapy       Date:  2011-10-31       Impact factor: 5.414

Review 2.  Paracrine mechanisms of stem cell reparative and regenerative actions in the heart.

Authors:  Maria Mirotsou; Tilanthi M Jayawardena; Jeffrey Schmeckpeper; Massimiliano Gnecchi; Victor J Dzau
Journal:  J Mol Cell Cardiol       Date:  2010-08-19       Impact factor: 5.000

Review 3.  Adhesion proteins, stem cells, and arrhythmogenesis.

Authors:  Nikki Gillum; Narine Sarvazyan
Journal:  Cardiovasc Toxicol       Date:  2008-01-05       Impact factor: 3.231

Review 4.  Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases.

Authors:  Farida Djouad; Carine Bouffi; Soufiane Ghannam; Danièle Noël; Christian Jorgensen
Journal:  Nat Rev Rheumatol       Date:  2009-07       Impact factor: 20.543

5.  Functions of Mesenchymal Stem Cells in Cardiac Repair.

Authors:  Selçuk Öztürk; Ayşe Eser Elçin; Yaşar Murat Elçin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  Exosomes Generated From iPSC-Derivatives: New Direction for Stem Cell Therapy in Human Heart Diseases.

Authors:  Ji-Hye Jung; Xuebin Fu; Phillip C Yang
Journal:  Circ Res       Date:  2017-01-20       Impact factor: 17.367

Review 7.  Stem cell paracrine actions and tissue regeneration.

Authors:  Priya R Baraniak; Todd C McDevitt
Journal:  Regen Med       Date:  2010-01       Impact factor: 3.806

8.  Cellular therapy for repair of cardiac damage after acute myocardial infarction.

Authors:  Matthew M Cook; Katarina Kollar; Gary P Brooke; Kerry Atkinson
Journal:  Int J Cell Biol       Date:  2009-03-29

9.  Cord lining-mesenchymal stem cells graft supplemented with an omental flap induces myocardial revascularization and ameliorates cardiac dysfunction in a rat model of chronic ischemic heart failure.

Authors:  Shera Lilyanna; Eliana C Martinez; Thang D Vu; Lieng H Ling; Shu U Gan; Ai L Tan; Thang T Phan; Theo Kofidis
Journal:  Tissue Eng Part A       Date:  2013-02-28       Impact factor: 3.845

10.  Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma.

Authors:  Jeffrey M Vainshtein; Rafi Kabarriti; Keyur J Mehta; Jayanta Roy-Chowdhury; Chandan Guha
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-07-15       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.